title: Compensation under the National Childhood Vaccine Injury Act.
abstract: The purpose of this article is to look at the effect of the federal compensation scheme under the National Childhood Vaccine Injury Act on the people and institutions involved in the administration of vaccinations. More vaccine-injured children will probably receive compensation than would have been true under state law, but each child will probably receive less money for damages. Manufacturers will pay excise taxes to fund the compensation scheme and receive, in return, substantial immunity from liability under state law. Although these provisions create incentives that work in opposite directions, producers likely will still have reason to improve the safety and efficacy of vaccines. The situation for those who administer vaccinations is less clear. Freeing them from the threat of litigation would leave them with little incentive to use immunizations appropriately because they do not contribute to the compensation scheme. Although Congress intended to make those who give vaccines immune from state claims, it may have failed to do so, leaving providers with their liability largely unchanged. The most pervasive uncertainty is that the Act is designed to self-destruct and may soon return vaccine-injured children, manufacturers, and providers to the state of the law before Congress acted.
authors.affiliation: Vanderbilt University School of Law, Nashville, TN 37240.
authors.forename: E W
authors.initials: EW
authors.lastname: Clayton
authors.forename: G B
authors.initials: GB
authors.lastname: Hickson
mesh_terms: D002648:Child; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence; D004345:Drug Industry; D005380:Financing, Government / Q000331:legislation & jurisprudence*; D006801:Humans; D010372:Pediatrics; D014481:United States; D014611:Vaccination / Q000191:economics / Q000331:legislation & jurisprudence*; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines